ILLUMINA INC (ILMN)

US4523271090 - Common Stock

116.09  -1.91 (-1.62%)

After market: 116.31 +0.22 (+0.19%)

Full profile views are only available for registered users, you can see which data is available below.

Examples of complete profiles are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional data.

ILLUMINA INC

NASDAQ:ILMN (7/12/2024, 7:00:02 PM)

After market: 116.31 +0.22 (+0.19%)

116.09

-1.91 (-1.62%)

Chartmill TA Rating
Chartmill Setup Rating
Sector
GICS SectorHealth Care
GICS IndustryLife Sciences Tools & Services
GICS SubIndustry
Chartmill FA Rating
Valuation
Growth
Profitability
Health
Dividend
Chartmill High Growth Momentum
EPS Q2Q%
Sales Q2Q%
CRS
6 Month-15.9%
Overview
Earnings (Last)
Earnings (Next)
Ins Owners
Inst Owners
Market Cap18.49B
Shares
PE131.92
Fwd PE45.25
Dividend YieldN/A
Analysts
IPO
Stock Screener Links
Screen Image

Nasdaq Stock Screener

Find more stocks on Nasdaq

Screen Image

USA Stock Screener

Find more stocks on the USA

Screen Image

GICS Sector Stock Screener

Find competitors from the same sector on the USA

Screen Image

GICS Industry Stock Screener

Find competitors from the same industry on the USA

Screen Image

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the USA

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Technical Competitors Stock Screener

Find the competitors with the best technical ratings on the USA

Screen Image

Best Technical Setups Competitors Stock Screener

Find the competitors with the best technical and setup ratings on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA

ILMN Daily chart

Company Profile

Illumina, Inc. engages in the development, manufacturing, and marketing of life science tools and integrated systems for large-scale analysis of genetic variation and function. The company is headquartered in San Diego, California and currently employs 11,500 full-time employees. The company went IPO on 2000-06-28. The firm operates through two segments: Core Illumina and GRAIL. Its Core Illumina segment offers products and services that serve customers in the research, clinical and applied markets, and enable the adoption of a variety of genomic solutions. Its GRAIL segment is a healthcare company focused on early detection of multiple cancers. Its portfolio of integrated sequencing and microarray systems, consumables, and analysis tools is designed to accelerate and simplify genetic analysis. Its BaseSpace Informatics Suite integrates directly with its sequencing instruments, allowing customers to manage their biological sample and sequencing runs, process and analyze the raw genomic data, and derive results. Its BeadArray technology combines microscopic beads and a substrate in a proprietary manufacturing process to produce arrays that can perform various assays simultaneously.

Company Info

ILLUMINA INC

5200 Illumina Way

San Diego CALIFORNIA 92122

P: 18582024500

CEO: Francis A. deSouza

Employees: 11500

Website: https://www.illumina.com

ILMN News

News Image3 days ago - Illumina, Inc.Illumina to Announce Second Quarter 2024 Financial Results on Tuesday, August 6, 2024

/PRNewswire/ -- As Illumina, Inc. (NASDAQ:ILMN) previously announced on June 24, the company will issue results for the second quarter 2024 following the close...

News Image4 days ago - Market News VideoNasdaq 100 Movers: INTU, ILMN
News Image5 days ago - Illumina, Inc.Illumina acquires Fluent BioSciences to accelerate single-cell analysis and discovery to a broader customer base

/PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, announced that effective today it has acquired...

News Image5 days ago - InvestorPlace3 Of the Best ETFs to Buy for AI Stocks Exposure

One of the best ways to gain max exposure to the unstoppable artificial intelligence boom is with popular AI ETFs.

News Image6 days ago - InvestorPlaceThe 3 Best Gene Editing Stocks to Buy in July 2024

Gene editing is revolutionizing medicine, creating substantial opportunities for some of the best gene editing stocks.

News Image9 days ago - InvestorPlace3 Biotech Stocks Turning DNA Dreams Into Dollars

Investors should consider buying into one of the future avenues of medicine by investing in these three BNA biotech stocks.

ILMN Twits

Here you can normally see the latest stock twits on ILMN, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.

Example Twits:

Twits example